Tempsens Instruments (India) IPO GMP Today, Price & Details
Tempsens Instruments (India) IPO GMP Today, Price Band, Subscription Status, Allotment & Listing Details
About Tempsens Instruments (India)
Tempsens Instruments (India) is a prominent player in the industrial heating solutions and process instrumentation sector, catering to a diverse range of industries including chemicals, pharmaceuticals, and automotive. The company manufactures a wide array of products such as industrial furnaces, ovens, temperature sensors, and control systems, establishing a significant footprint both domestically and internationally.
Financially, the company has demonstrated a robust performance, reporting revenues of ₹455.86 Cr and a Profit After Tax (PAT) of ₹71.07 Cr. The IPO is structured as a combination of a fresh issue of ₹95 Cr and an Offer for Sale (OFS) of ₹555 Cr, bringing the total issue size to a substantial ₹650 Cr. This structure suggests a mix of capital infusion for growth and an exit opportunity for existing shareholders.
Tempsens Instruments appears to hold a competitive edge due to its extensive product portfolio and established market presence. The funds raised from the fresh issue are earmarked for working capital requirements and general corporate purposes, aiming to fuel further expansion and operational efficiency. This IPO presents an opportunity for investors to participate in a well-established player within the manufacturing and instrumentation domain.
Tempsens Instruments (India) IPO — Investment Analysis
The IPO is priced within a band of ₹285 to ₹300 per share, with a face value of ₹4. The company has reported an Earnings Per Share (EPS) of ₹82.11, leading to a P/E ratio of approximately 35.38x at the upper end of the price band. This valuation needs to be assessed against industry peers and the company's growth prospects. While a P/E of 35.38x might seem on the higher side, it's crucial to consider the company's profitability and the potential for future earnings growth. Investors should scrutinize whether the current pricing adequately reflects the company's long-term potential or if it's priced for perfection.
In terms of financial health, Tempsens Instruments has shown commendable revenue figures of ₹455.86 Cr and a PAT of ₹71.07 Cr. This translates to a healthy profit margin. While specific EBITDA figures and return ratios like Return on Net Worth (RONW) and Return on Capital Employed (ROCE) aren't explicitly provided in the data, the reported PAT suggests a profitable operation. A deeper dive into these metrics would offer a clearer picture of the company's operational efficiency and its ability to generate returns for shareholders.
The growth outlook for Tempsens Instruments seems promising, given its established presence in a growing industrial sector. However, the significant portion of the IPO being an Offer for Sale (OFS) at ₹555 Cr out of a total issue size of ₹650 Cr is a point to consider. While OFS allows existing investors to exit, it means less capital is coming into the company for expansion. Sector-specific risks, such as cyclical demand and technological obsolescence, also need to be factored in. The company's ability to maintain its competitive edge and adapt to evolving industry needs will be key.
Subscription levels from Qualified Institutional Buyers (QIBs), High Net-worth Individuals (HNIs), and Retail investors will be a crucial indicator of market sentiment. High subscription rates across all categories often signal strong demand, potentially leading to a positive listing. Conversely, muted subscriptions might suggest cautious investor sentiment. It's important to monitor these subscription figures closely as they unfold. Investors should consult a SEBI-registered financial advisor before making investment decisions.
Disclaimer: This analysis is auto-generated from publicly available financial data and should not be considered investment advice. Always consult a SEBI-registered financial advisor before making investment decisions.
Tempsens Instruments (India) IPO — Pros & Cons
Strengths
- The company has achieved a commendable revenue of ₹455.86 Cr and a PAT of ₹71.07 Cr, showcasing a strong financial performance. This profitability indicates a solid business model and efficient operations, which can be attractive for long-term investors.
- Tempsens Instruments operates in a sector with consistent demand driven by industrial growth, suggesting a stable revenue stream. This stability can provide a degree of resilience for the investment, even during economic fluctuations.
- The IPO includes a fresh issue component of ₹95 Cr, which will be utilized for working capital and general corporate purposes. This infusion of capital can support the company's expansion plans and enhance its operational capabilities, potentially leading to future growth.
- The company has a diverse product portfolio catering to various industries, reducing reliance on any single sector. This diversification can mitigate risks associated with downturns in specific industries, offering a more balanced investment profile.
- The IPO is managed by reputable lead managers, ICICI Securities Ltd. and JM Financial Ltd., and the registrar is Kfin Technologies Ltd. This indicates a well-structured and professionally managed offering, which can instill confidence among investors regarding transparency and compliance.
Risks
- The IPO has a significant Offer for Sale (OFS) component of ₹555 Cr out of a total issue size of ₹650 Cr. This means a large portion of the proceeds will go to exiting shareholders rather than directly into the company's growth initiatives, which might limit the immediate capital available for expansion.
- The P/E ratio of approximately 35.38x at the upper price band of ₹300 might be considered high compared to some industry benchmarks, suggesting that the IPO could be priced at a premium. Investors need to carefully evaluate if the growth prospects justify this valuation.
- While profitability is strong, specific details on margins and return ratios like RONW and ROCE are not readily available in the provided data. A lack of granular financial metrics can make it challenging for investors to conduct a thorough assessment of the company's efficiency and shareholder value creation.
- The industrial sector, which Tempsens Instruments serves, can be cyclical and subject to economic downturns. Any slowdown in industrial activity could impact the company's revenues and profitability, posing a risk to investor returns.
- The face value of the shares is ₹4, and the price band is ₹285 to ₹300. This implies a significant premium over the face value, which is common for mainboard IPOs but still warrants attention from investors sensitive to such valuations.
Tempsens Instruments (India) IPO Details
| Company Name | Tempsens Instruments (India) |
|---|---|
| IPO Type | MAINBOARD |
| Exchange | NSE |
| Price Band | ₹285 - ₹300 |
| Face Value | ₹4 per share |
| Lot Size | 50 shares |
| Min Investment | ₹15,000 |
| Total Issue Size | ₹650.00 Cr |
|---|---|
| Fresh Issue | ₹95.00 Cr |
| Offer for Sale | ₹555.00 Cr |
| Registrar | Kfin Technologies Ltd. |
| Lead Manager | ICICI Securities Ltd., JM Financial Ltd. |
| IPO Status | Listed |
Tempsens Instruments (India) IPO Dates
Tempsens Instruments (India) IPO Subscription Status
Tempsens Instruments (India) IPO Listing Performance
Tempsens Instruments (India) IPO listed on NSE on 27 Aug 2026 at ₹631, a premium of 110.4% over the issue price of ₹300. Investors who received allotment made a profit of ₹16,560 per lot (50 shares) on listing day.
Tempsens Instruments (India) IPO — Key Highlights
- The total IPO issue size is a significant ₹650 Cr, comprising a fresh issue of ₹95 Cr and an OFS of ₹555 Cr.
- Tempsens Instruments reported impressive revenue of ₹455.86 Cr and PAT of ₹71.07 Cr in its latest financials.
- The P/E ratio is calculated at 35.38x, based on an EPS of ₹82.11 and the upper price band of ₹300.
- The company operates with a price band of ₹285 to ₹300 per share.
- A single lot size for this IPO is 50 shares.
- ICICI Securities Ltd. and JM Financial Ltd. are the lead managers for this mainboard IPO.
Tempsens Instruments (India) Financial Performance
| Revenue | ₹455.86 Cr |
|---|---|
| PAT | ₹71.07 Cr |
| EPS | ₹8,211.00 |
Tempsens Instruments (India) IPO Valuations & Key Metrics
Valuation Ratios
| EPS | ₹8,211.00 |
|---|---|
| P/E Ratio | 35.38x |
| Debt/Equity | 0.000 |
Return Metrics
Tempsens Instruments (India) IPO Reservation / Allocation
Tempsens Instruments (India) IPO Lead Manager & Registrar
Book Running Lead Manager
ICICI Securities Ltd., JM Financial Ltd.
IPO Registrar
Kfin Technologies Ltd.
Tempsens Instruments (India) IPO — Frequently Asked Questions
What is Tempsens Instruments (India) IPO GMP today?
As of today, the Grey Market Premium (GMP) for Tempsens Instruments (India) IPO is ₹285 per share, indicating a potential listing premium of 95% above the issue price of ₹300.
What is the price band and lot size of Tempsens Instruments (India) IPO?
Tempsens Instruments (India) IPO has a price band of ₹285 to ₹300 per equity share with a face value of ₹4. The minimum lot size is 50 shares, requiring a minimum investment of ₹15,000 at the upper band.
What are the important dates for Tempsens Instruments (India) IPO?
Tempsens Instruments (India) IPO opens for subscription on 20 Aug 2026 and closes on 24 Aug 2026. Allotment is expected on 25 Aug 2026. The shares are expected to list on NSE on 27 Aug 2026.
What is the investor category allocation in Tempsens Instruments (India) IPO?
The shares are reserved as follows — Qualified Institutional Buyers (QIB): 0.00%, Non-Institutional Investors (NII/HNI): 0.00%, and Retail Individual Investors: 35.00%.
How can I apply for Tempsens Instruments (India) IPO?
You can apply for Tempsens Instruments (India) IPO through your bank's net banking ASBA facility or via UPI-based application through any stockbroker platform. Ensure you have sufficient funds in your bank account as the amount will be blocked until allotment. The registrar for this IPO is Kfin Technologies Ltd..
What is the subscription status of Tempsens Instruments (India) IPO?
Tempsens Instruments (India) IPO has been subscribed 314.44 times overall. Retail category: 61.00x, NII/HNI: 314.44x, QIB: 302.88x.
What is Tempsens Instruments (India) IPO price band and lot size?
The IPO for Tempsens Instruments (India) is open with a price band set between ₹285 and ₹300 per share. Each lot comprises 50 shares, meaning the minimum investment required is ₹15,000 (50 shares x ₹300). The face value of each share is ₹4.
Is Tempsens Instruments (India) IPO worth investing in?
Tempsens Instruments has demonstrated strong financials with revenues of ₹455.86 Cr and PAT of ₹71.07 Cr. Its P/E ratio stands at approximately 35.38x, which investors should compare with industry peers.
However, the large OFS component of ₹555 Cr is a key consideration. Investors should weigh the company's growth potential against its valuation and the structure of the IPO. Investors should consult a SEBI-registered financial advisor before making investment decisions.
What is Tempsens Instruments (India) IPO GMP today?
Grey Market Premium (GMP) for the Tempsens Instruments (India) IPO is an unofficial indicator of market sentiment and demand. It reflects the price at which IPO shares are trading in the grey market before they are listed on exchanges. While a positive GMP, often quoted as a percentage or a fixed amount over the IPO price, can suggest potential listing gains, it's crucial to remember that GMP is speculative and not guaranteed.
Investors should not rely solely on GMP for investment decisions, as it can fluctuate significantly and is not regulated by SEBI. Always conduct thorough research beyond GMP figures.
How to apply for Tempsens Instruments (India) IPO?
You can apply for the Tempsens Instruments (India) IPO through either the UPI (Unified Payments Interface) or ASBA (Application Supported by Blocked Amount) facility. Most brokers facilitate online applications via their trading platforms, allowing you to block funds in your bank account for the IPO amount. The registrar for this IPO is Kfin Technologies Ltd.
Your funds will remain blocked in your bank account until the shares are allotted to you.